Sudomotor dysfunction in people with type 1 diabetes with and without clinical peripheral neuropathy: A study from Pune, India
Rohan Shah, Rishikesh Behere, Aboli Bhalerao, Sanat Phatak, Alma Baptist, Chinmay S Marathe, Chittaranjan S Yajnik · 2026
Read Sudomotor dysfunction in people with type 1 diabetes with and without clinical peripheral neuropathy: A study from Pune, India by Rohan Shah, Rishikesh Behere, Aboli Bhalerao, Sanat Phatak, Alma Baptist, Chinmay S Marathe, Chittaranjan S Yajnik (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13398954.txt.
Description
Rohan Shah and colleagues compare sweat gland testing against standard screening for early nerve damage in type 1 diabetes. Their 2026 study runs at KEM Hospital in Pune, India, within the prospective PICTURE cohort. Usual screens miss early peripheral neuropathy, while sweat dysfunction ranks among its first signs and can be measured by the SUDOSCAN device.
In all, 264 participants, mean age 26.3 years with diabetes for 13.2 years on average, took both the device test and the Michigan screening instrument together. Sweat dysfunction appeared in 46.2 percent against 22.3 percent flagged clinically in the results given. Sensitivity of 72.8 percent and specificity of 61.4 percent for the device frame it as an early-warning complement, not a replacement.
Catalog record
| CREATOR | Rohan Shah, Rishikesh Behere, Aboli Bhalerao, Sanat Phatak, Alma Baptist, Chinmay S Marathe, Chittaranjan S Yajnik |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42847 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |